1. Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition. (February 2020) Authors: Boers, Jorianne; Venema, Clasina M.; de Vries, Erik F.J.; Glaudemans, Andor W.J.M.; Kwee, Thomas C.; Schuuring, Ed; Martens, John W.M.; Elias, Sjoerd G.; Hospers, Geke A.P.; Schröder, Carolina P. Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience. (November 2016) Authors: Venema, Clasina M.; Apollonio, Giulia; Hospers, Geke A.P.; Schröder, Carolina P.; Dierckx, Rudi A.J.O.; de Vries, Erik F.J.; Glaudemans, Andor W.J.M. Journal: Clinical nuclear medicine Issue: Volume 41:Number 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer. (February 2021) Authors: Boers, Jorianne; Venema, Clasina M.; de Vries, Erik F.J.; Hospers, Geke A.P.; Boersma, Hendrikus H.; Rikhof, Bart; Dorbritz, Christine; Glaudemans, Andor W.J.M.; Schröder, Carolina P. Journal: European journal of cancer Issue: Volume 144(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗